Possible therapeutic option of aqueous plasma for refractory ovarian cancer

MLA

Shinya Toyokuni, et al. “Possible Therapeutic Option of Aqueous Plasma for Refractory Ovarian Cancer.” Clinical Plasma Medicine, vol. 4, July 2016, pp. 14–18. EBSCOhost, https://doi.org/10.1016/j.cpme.2015.12.002.

APA

Shinya Toyokuni, Masaaki Mizuno, Hiroaki Kajiyama, Fumitaka Kikkawa, Kae Nakamura, Hiromasa Tanaka, Fumi Utsumi, & Masaru Hori. (2016). Possible therapeutic option of aqueous plasma for refractory ovarian cancer. Clinical Plasma Medicine, 4, 14–18. https://doi.org/10.1016/j.cpme.2015.12.002

Chicago

Shinya Toyokuni, Masaaki Mizuno, Hiroaki Kajiyama, Fumitaka Kikkawa, Kae Nakamura, Hiromasa Tanaka, Fumi Utsumi, and Masaru Hori. 2016. “Possible Therapeutic Option of Aqueous Plasma for Refractory Ovarian Cancer.” Clinical Plasma Medicine 4 (July): 14–18. doi:10.1016/j.cpme.2015.12.002.